However, some of the genes harboring AT/RT-unique differentiation–demethylated DMRs with EZH2 binding, such as TNK1, are found to be relevant in cancer development (Hong et al, 2020) and have not been associated with nBAF or late neural development. The gene discussed is EZH2; the disease is cancer.